Cargando…

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases

SIMPLE SUMMARY: HER2+ breast cancer patients are treated with agents that tag HER2+ tumour cells for elimination by the immune system, down-modulate HER2 activity and/or block the formation of HER2 dimers, including the neuregulin-1 receptor, HER2-HER3. HER2-targeted therapies prolong survival by lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Malcolm, Nguyen, Tam H., Niland, Colleen, Reid, Lynne E., Jat, Parmjit S., Saunus, Jodi M., Lakhani, Sunil R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833370/ https://www.ncbi.nlm.nih.gov/pubmed/35158800 http://dx.doi.org/10.3390/cancers14030533

Ejemplares similares

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
por: Croft, Priyakshi Kalita-de, et al.
Publicado: (2021)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2022)

Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2019)

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2019)

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence
por: Rabbie, Roy, et al.
Publicado: (2020)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines
por: Alexopoulou, Annika N, et al.
Publicado: (2010)

COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis
por: Hancock, Janelle L., et al.
Publicado: (2023)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018)

Deciphering the role of Nuclear Factor-κB in cellular senescence
por: Vaughan, Simon, et al.
Publicado: (2011)

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
por: Kumari, Ruchi, et al.
Publicado: (2021)

N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
por: Shewell, Lucy K., et al.
Publicado: (2022)

SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer
por: Burgess, Joshua T., et al.
Publicado: (2016)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

LobSig is a multigene predictor of outcome in invasive lobular carcinoma
por: McCart Reed, Amy E., et al.
Publicado: (2019)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

A new obligate CXCL4–CXCL12 heterodimer for studying chemokine heterodimer activities and mechanisms
por: Nguyen, Khanh T.P., et al.
Publicado: (2022)

Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence
por: Mowla, Sophia N, et al.
Publicado: (2013)

Identification of clinical target areas in the brainstem of prion‐infected mice
por: Mirabile, Ilaria, et al.
Publicado: (2015)

Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
por: Kalaw, Emarene, et al.
Publicado: (2020)

Equimolar heterodimers in microtubules
Publicado: (1982)

Heterodimers reign in the embryo
por: Tajer, Benjamin, et al.
Publicado: (2017)

Cellular senescence and aging: the role of B-MYB
por: Mowla, Sophia N, et al.
Publicado: (2014)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
por: Zhao, Wei, et al.
Publicado: (2022)

In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
por: Smart, Chanel E., et al.
Publicado: (2013)

Correction: In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
por: Smart, Chanel E., et al.
Publicado: (2013)

An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
por: Rovillain, Emilie, et al.
Publicado: (2011)

Conformational landscape of the epidermal growth factor receptor kinase reveals a mutant specific allosteric pocket
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2018)

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
por: Duchnowska, Renata, et al.
Publicado: (2012)

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
por: Kelly, William J., et al.
Publicado: (2018)

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
por: Bhatt, Vijaya Raj, et al.
Publicado: (2016)

The marriage of chemokines and galectins as functional heterodimers
por: von Hundelshausen, Philipp, et al.
Publicado: (2021)

Modeling the Heterodimer Interfaces of Melatonin Receptors
por: Tse, Lap Hang, et al.
Publicado: (2021)

The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin
por: Peters, Amelia A., et al.
Publicado: (2016)

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry
por: Laakmann, E., et al.
Publicado: (2022)

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status
por: Li, Hongwei, et al.
Publicado: (2017)

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

A view on the landscape of breast cancer brain metastases
por: Malani, Rachna
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_apm2s86uvu0e2l5hr11nf37lm7